STSRX Mutual Fund

STSRX Mutual Fund (American Beacon Stephens Small Cap Growth Fund) is managed by American Beacon Funds with $95,455.8 in net assets. STSRX expense ratio is 0.96%, holding 98 positions across sectors including Information Technology, Health Care, Industrials. Inception date: 2019-04-30.

STSRX performance shows a YTD return of 12.54%. The 1-year return is 11.71% and the 5-year return is 4.09%.

STSRX top holdings include Halozyme Therapeutics Inc (2.0%), Ligand Pharmaceuticals, Inc. (2.0%), Repligen Corp (1.9%), Firstcash Inc (1.9%), Xometry, Inc. (1.9%). Go to all STSRX holdings, STSRX sectors, or STSRX dividends.

STSRX can be compared against other funds. Use STSRX overlap to find shared positions, or STSRX vs another fund for a side-by-side view. STSRX alternatives are available via the screener, along with tax-loss harvesting opportunities.